Log in
menu
RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact
All Categories
--------------
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
search
arrow_back_ios
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
arrow_forward_ios
Home
Companies
Agios Pharmaceuticals Inc
history
edit
build
Agios Pharmaceuticals Inc
performance profile
WikiRate ID:
3050182
Headquarters:
Massachusetts (United States)
bookmark
0
Answers
188
Sources
11
Groups
2
Data Sets
5
Details
Filters
Status:
all
close
Data Set:
prova sasb
close
Clear All
filter_list
ALL FILTERS
Answers
63
Sort
Year
Metric
Answer
2020
Comprehensive Income Net of Tax
Research
lock_open
-327M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Net Income Attributable to the company
Research
lock_open
-327M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Assets
Research
lock_open
853M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Cost of Goods and Services Sold
Research
lock_open
2.81M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Effective Income Tax Rate Continuing Operations
Research
lock_open
0
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Income Loss From Continuing Operations Before Income Taxes Foreign
Research
lock_open
1.36M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2020
Research and Development Expense
Research
lock_open
367M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Comprehensive Income Net of Tax
Research
lock_open
-409M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Net Income Attributable to the company
Research
lock_open
-411M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Assets
Research
lock_open
891M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Cost of Goods and Services Sold
Research
lock_open
1.32M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Effective Income Tax Rate Continuing Operations
Research
lock_open
0
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Income Loss From Continuing Operations Before Income Taxes Foreign
Research
lock_open
21.1M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Income Tax Expense Benefit
Research
lock_open
0
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2019
Research and Development Expense
Research
lock_open
411M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Comprehensive Income Net of Tax
Research
lock_open
-347M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Net Income Attributable to the company
Research
lock_open
-346M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Assets
Research
lock_open
858M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Cost of Goods and Services Sold
Research
lock_open
1.4M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Effective Income Tax Rate Continuing Operations
Research
lock_open
0
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
«
1
2
3
4
»
1 - 20 of 63